348 related articles for article (PubMed ID: 15857428)
1. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
Sills GJ; Mohanraj R; Butler E; McCrindle S; Collier L; Wilson EA; Brodie MJ
Epilepsia; 2005 May; 46(5):643-7. PubMed ID: 15857428
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance in patients undergoing resective epilepsy surgery is not associated with C3435T polymorphism in the ABCB1 (MDR1) gene.
Dericioglu N; Babaoglu MO; Yasar U; Bal IB; Bozkurt A; Saygi S
Epilepsy Res; 2008 Jul; 80(1):42-6. PubMed ID: 18436433
[TBL] [Abstract][Full Text] [Related]
3. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
4. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1.
Siddiqui A; Kerb R; Weale ME; Brinkmann U; Smith A; Goldstein DB; Wood NW; Sisodiya SM
N Engl J Med; 2003 Apr; 348(15):1442-8. PubMed ID: 12686700
[TBL] [Abstract][Full Text] [Related]
5. MDR1 gene polymorphisms and risk of gingival hyperplasia induced by calcium antagonists.
Meisel P; Giebel J; Kunert-Keil C; Dazert P; Kroemer HK; Kocher T
Clin Pharmacol Ther; 2006 Jan; 79(1):62-71. PubMed ID: 16413242
[TBL] [Abstract][Full Text] [Related]
6. Effect of MDR1 polymorphism on multidrug resistance expression in breast cancer patients.
Taheri M; Mahjoubi F; Omranipour R
Genet Mol Res; 2010 Jan; 9(1):34-40. PubMed ID: 20082268
[TBL] [Abstract][Full Text] [Related]
7. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis.
Schwab M; Schaeffeler E; Marx C; Fromm MF; Kaskas B; Metzler J; Stange E; Herfarth H; Schoelmerich J; Gregor M; Walker S; Cascorbi I; Roots I; Brinkmann U; Zanger UM; Eichelbaum M
Gastroenterology; 2003 Jan; 124(1):26-33. PubMed ID: 12512026
[TBL] [Abstract][Full Text] [Related]
8. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG
Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance 1 (MDR1) gene polymorphisms in childhood drug-resistant epilepsy.
Alpman A; Ozkinay F; Tekgul H; Gokben S; Pehlivan S; Schalling M; Ozkinay C
J Child Neurol; 2010 Dec; 25(12):1485-90. PubMed ID: 20448249
[TBL] [Abstract][Full Text] [Related]
10. Association of MDR1 (C3435T) polymorphism and resistance to carbamazepine in epileptic patients from Turkey.
Ozgon GO; Bebek N; Gul G; Cine N
Eur Neurol; 2008; 59(1-2):67-70. PubMed ID: 17917461
[TBL] [Abstract][Full Text] [Related]
11. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.
Seo T; Ishitsu T; Ueda N; Nakada N; Yurube K; Ueda K; Nakagawa K
Pharmacogenomics; 2006 Jun; 7(4):551-61. PubMed ID: 16753003
[TBL] [Abstract][Full Text] [Related]
12. Association between multidrug resistance 1 (MDR1) gene polymorphisms and therapeutic response to bromperidol in schizophrenic patients: a preliminary study.
Yasui-Furukori N; Saito M; Nakagami T; Kaneda A; Tateishi T; Kaneko S
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):286-91. PubMed ID: 16386826
[TBL] [Abstract][Full Text] [Related]
13. Influence of C3435T multidrug resistance gene-1 (MDR-1) polymorphism on platelet reactivity and prognosis in patients with acute coronary syndromes.
Spiewak M; Małek ŁA; Kostrzewa G; Kisiel B; Serafin A; Filipiak KJ; Płoski R; Opolski G
Kardiol Pol; 2009 Aug; 67(8):827-34. PubMed ID: 19784880
[TBL] [Abstract][Full Text] [Related]
14. The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patients.
Zheng HX; Zeevi A; McCurry K; Schuetz E; Webber S; Ristich J; Zhang J; Iacono A; Dauber J; McDade K; Zaldonis D; Lamba J; Burckart GJ
Transpl Immunol; 2005 Mar; 14(1):37-42. PubMed ID: 15814280
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: a meta-analysis.
Bournissen FG; Moretti ME; Juurlink DN; Koren G; Walker M; Finkelstein Y
Epilepsia; 2009 Apr; 50(4):898-903. PubMed ID: 19178561
[TBL] [Abstract][Full Text] [Related]
16. Association of ABCB1 genetic variants 3435C>T and 2677G>T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients.
Mosyagin I; Runge U; Schroeder HW; Dazert E; Vogelgesang S; Siegmund W; Warzok RW; Cascorbi I
Epilepsia; 2008 Sep; 49(9):1555-61. PubMed ID: 18494787
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study.
Ebid AH; Ahmed MM; Mohammed SA
Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887
[TBL] [Abstract][Full Text] [Related]
18. Distribution of allelic variants of functional C3435T polymorphism of drug transporter MDR1 gene in a sample of Polish population.
Jamroziak K; Balcerczak E; Młynarski W; Mirowski M; Robak T
Pol J Pharmacol; 2002; 54(5):495-500. PubMed ID: 12593536
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver.
Owen A; Goldring C; Morgan P; Chadwick D; Park BK; Pirmohamed M
Br J Clin Pharmacol; 2005 Mar; 59(3):365-70. PubMed ID: 15752383
[TBL] [Abstract][Full Text] [Related]
20. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.
Illmer T; Schuler US; Thiede C; Schwarz UI; Kim RB; Gotthard S; Freund D; Schäkel U; Ehninger G; Schaich M
Cancer Res; 2002 Sep; 62(17):4955-62. PubMed ID: 12208746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
